Project Number PTC REG-20-653530 Agency/Funding Organization Alzheimer's Association Funding Year 2020 View Full Project Details for Evaluating oral semaglutide as a treatment for Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 10. Metabolism and Bioenergetics b. Insulin Resistance and Type II Diabetes Researcher and Organization Principal Investigator Edison, Paul Principal Investigator First Name Paul Principal Investigator Last Name Edison Awardee Organization Imperial College of Science, Technology and Medicine Contact PI Country United Kingdom Project Detail FY Overall Cost $915,654 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Alzheimer Association
